AxoGen and Blueprint Medicines Help Opaleye Return 91% Over the Last Year
James A. Silverman founded Opaleye Management back in 1996 and it was formerly known as Risk/Reward Capital.
Hedge Fund - Opaleye Management
News, Interviews, and Investor Letters
- Displaying 5
13G Filing: Opaleye Management and Inotek Pharmaceuticals Corp (ITEK)
Inotek Pharmaceuticals Corp (NASDAQ:ITEK): James A. Silverman's Opaleye Management filed an amended 13D.
You can check out Opaleye Management's latest holdings and filings here.
13G Filing: Opaleye Management and Tonix Pharmaceuticals Holding Corp. (TNXP)
You can access the original SEC filing by clicking here.
This Healthcare Fund Just Had A Huge Q3: Here's How
The mainstream media likes taking shots at hedge funds because they are easy targets.
More Than 60% Returns For These Two Hedgies' Favorite Health Care Picks
The health care sector has appreciated by nearly 30% over the past year. We decided to take a look at three companies that two health care-focused funds, namely James A.